Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorANTONAZZO, Ippazio Cosimo
dc.contributor.authorFORNARI, Carla
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMAUMUS-ROBERT, Sandy
dc.contributor.authorCEI, Eleonora
dc.contributor.authorPAOLETTI, Olga
dc.contributor.authorFERRARA, Pietro
dc.contributor.authorCONTI, Sara
dc.contributor.authorCORTESI, Paolo Angelo
dc.contributor.authorMANTOVANI, Lorenzo Giovanni
dc.contributor.authorGINI, Rosa
dc.contributor.authorMAZZAGLIA, Giampiero
dc.date.accessioned2022-03-16T09:58:37Z
dc.date.available2022-03-16T09:58:37Z
dc.date.issued2022-01-28
dc.identifier.issn2075-4426en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/136483
dc.description.abstractEnIn Italy, during the COVID-19 waves two lockdowns were implemented to prevent virus diffusion in the general population. Data on antidepressant (AD) use in these periods are still scarce. This study aimed at exploring the impact of COVID-19 lockdowns on prevalence and incidence of antidepressant drug use in the general population. A population-based study using the healthcare administrative database of Tuscany was performed. We selected a dynamic cohort of subjects with at least one ADs dispensing from 1 January 2018 to 27 December 2020. The weekly prevalence and incidence of drug use were estimated across different segments: pre-lockdown (1 January 2018-8 March 2020), first lockdown (9 March 2020-15 June 2020), post-first lockdown (16 June 2020-15 November 2020) and second lockdown (16 November 2020-27 December 2020). An interrupted time-series analysis was used to assess the effect of lockdowns on the observed outcomes. Compared to the pre-lockdown we observed an abrupt reduction of ADs incidence (Incidence-Ratio: 0.82; 95% Confidence-Intervals: 0.74-0.91) and a slight weekly decrease of prevalence (Prevalence-Ratio: 0.997; 0.996-0.999). During the post-first lockdown AD use increased, with higher incidence- and similar prevalence values compared with those expected in the absence of the outbreak. This pandemic has impacted AD drug use in the general population with potential rebound effects during the period between waves. This calls for future studies aimed at exploring the mid-long term effects of this phenomenon.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enCOVID-19
dc.subject.enAntidepressants
dc.subject.enPharmacoepidemiology
dc.subject.enHealthcare administrative database
dc.subject.enLockdown
dc.title.enAntidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis
dc.typeArticle de revueen_US
dc.identifier.doi10.3390/jpm12020178en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35207666en_US
bordeaux.journalJournal of Personalized Medicineen_US
bordeaux.volume12en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue2en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamAHEAD_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03610161
hal.version1
hal.date.transferred2022-03-16T09:58:40Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Personalized%20Medicine&rft.date=2022-01-28&rft.volume=12&rft.issue=2&rft.eissn=2075-4426&rft.issn=2075-4426&rft.au=ANTONAZZO,%20Ippazio%20Cosimo&FORNARI,%20Carla&MAUMUS-ROBERT,%20Sandy&CEI,%20Eleonora&PAOLETTI,%20Olga&rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record